Use of psychotropic medications for patients with office visits who receive a diagnosis of panic disorder

Medical Care

Volumn 42, Issue 12, 2004, Pages 1242-1246

  Blanco, Carlos ^a,b   Goodwin, Renee D ^b   Liebowitz, Michael R ^a   Schmidt, Andrew B ^a   Lewis Fernández, Roberto ^a   Olfson, Mark ^a  

^a Departments of Psychiatry and Behavioral Sciences   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Panic disorder; Primary care; Treatment trends

Indexed keywords

BENZODIAZEPINE DERIVATIVE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AMBULATORY CARE; ARTICLE; DRUG USE; HUMAN; LOGISTIC REGRESSION ANALYSIS; PANIC; PRESCRIPTION; PRIMARY MEDICAL CARE;

EID: 10344265921     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200412000-00011     Document Type: Article

References (21)

1. Eaton WW, Kessler RC, Wittchen HU, et al. Panic and panic disorder in the United States. Am J Psychiatry. 1994;151:413-420.
2. Simon GE. Psychiatric disorder and functional somatic symptoms as predictors of health care use. Psychiatr Med. 1992;10:49-59.
3. Katernadale L, Realini JP. Use of healthcare services by persons with panic disorder. Psychiatr Ser. 1997;48:1027-1032.
4. Black DW, Wesner R, Bowers W, et al. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry. 1993;50:44-50.
5. Ballenger JC, Wheadon DE, Steiner M, et al. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry. 1998;155:36-42.
6. Pollack MH, Otto MW, Worthington JJ, et al. Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial. Arch Gen Psychiatry. 1998;55:1010-1016.
7. Tesar GE, Rosenbaum JF, Pollack MH, et al. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry. 1991;52:69-76.
8. DeMartinis NA, Schweizer F. An open-label trial of nefazodone in high comorbidity panic disorder. J Clin Psychiatry. 1996;57:245-248.
9. Regier DA, Narrow WE, Rae DS, et al. The de facto US mental and addictive disorders service system. Epidemiologic catchment area prospective 1-year prevalence rates of disorders and services. Arch Gen Psychiatry. 1993;50:85-94.
10. Blanco C, Laje G, Olfson M, et al. Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry. 2002;159:1005-1010.
11. Goodwin R. Gould MS. Blanco C. Prescription of psychotropic medications to youths in office-based practice. Psychiatric Ser. 2001;52:1081-1087.
12. Olfson M, Marcus SC, Pincus HA, et al. Antidepressant prescribing practices of outpatient psychiatrists. Arch General Psychiatry. 1998;55:310-316.
13. Pincus HA, Tanielian TL, Marcus SC, et al. Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA. 1998;279:526-531.
14. Potthoff RF, Woodbury MA, Manton KG. "Equivalence sample size" and "equivalent degrees of freedom" refinements for inference using survey weights under superpopulation models. J Am Stat Assoc. 1992;87:383-396.
15. Robins LN, Regier DS, eds. Psychiatric Disorders in America. New York: Free Press; 1991:27-28.
16. Rogers EM. Diffusion of Innovations. New York, Free Press, 1995.
17. Bruce SE, Vasile RG, Goisman RM, et al. Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry. 2003;160:1432-1438.
18. Ballenger JC, Lydiard RB. Panic disorder: Results of a patient survey. Human Psychopharmacol. 1997;12:S27-S23.
19. Marchesi C, Ampollin P, Signifredi R, et al. The treatment of panic disorder in a clinical setting: a 12-month naturalistic study. Neuropsychobiology. 1997;36:25-31.
20. Roy-Byrne P, Russo J, Dugdale DC, et al. Undertreatment of panic disorder in primary care: role of patient and physician characteristics. J Am Board Fam Pract. 2002;15:443-450.
21. Hazlett-Stevens H, Craske MG, Roy-Byrne PP, et al. Predictors of willingness to consider medication and psychosocial treatment for panic disorder in primary care patients. Gen Hosp Psychiatry. 2002;24:316-321.